To avoid the impacts of chemotherapy on PBMCs from GC patients, we further explored whether P1 could lead to the induction of NRT cells derived from healthy donors that specifically target the CLDN18 (exon 5)-ARHGAP26 (exon 12) fusion. The gene discussed is CLDN18; the disease is gastric cancer.